Correlation between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel Disease
Background. Current biomarkers have been routinely used noninvasive methods for assessing disease activity of inflammatory bowel disease (IBD), but none of them are specific. This study was aimed to determine the performance of the serological biomarkers for detecting disease activity in patients wi...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2019/6517549 |
id |
doaj-332f46389c6549d0b7c45bcaeeb84ee4 |
---|---|
record_format |
Article |
spelling |
doaj-332f46389c6549d0b7c45bcaeeb84ee42020-11-25T00:12:54ZengHindawi LimitedBioMed Research International2314-61332314-61412019-01-01201910.1155/2019/65175496517549Correlation between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel DiseaseMengque Xu0Mengsha Cen1Xiaoli Chen2Haotian Chen3Xing Liu4Qian Cao5Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaDepartment of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaDepartment of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaDepartment of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaDepartment of Medical Records and Statistics, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaDepartment of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaBackground. Current biomarkers have been routinely used noninvasive methods for assessing disease activity of inflammatory bowel disease (IBD), but none of them are specific. This study was aimed to determine the performance of the serological biomarkers for detecting disease activity in patients with IBD. Methods. A prospective study that included 73 ulcerative disease (UC) subjects, 141 Crohn’s disease (CD) subjects, and 30 of them complicated with C. difficile infection (CDI) were diagnosed at a single-institution IBD center. Disease activity was assessed using by Truelove and Witts criteria for UC and Harvey Bradshaw Simple Index for CD. Serological inflammatory biomarkers were compared in different severity groups. Receiver operator curve analyses assessed the performance of each biomarker in discriminating disease states. Results. For UC patients, elevated monocyte counts, C-reactive protein (CRP), and decreased lymphocyte counts and lymphocyte/monocyte ratio (LMR) significantly differed between subjects with active and inactive UC. LMR of 3.1 was 76% sensitive and had a specificity of 67% for active UC. For CD patients, higher values of neutrophils, monocytes, neutrophil/lymphocyte ratio, CRP, fibrinogen, and lower values of LMR and hemoglobin were significantly different between subjects with active and inactive CD. None of the biomarkers included had a good correlation with disease activity (area under the ROC Curve < 0.70). Conclusions. A low LMR represents an inexpensive, readily available test with a promising value to identify disease activity in UC patients, whereas none of the inflammatory biomarkers showed a discriminative value in disease activity of CD.http://dx.doi.org/10.1155/2019/6517549 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mengque Xu Mengsha Cen Xiaoli Chen Haotian Chen Xing Liu Qian Cao |
spellingShingle |
Mengque Xu Mengsha Cen Xiaoli Chen Haotian Chen Xing Liu Qian Cao Correlation between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel Disease BioMed Research International |
author_facet |
Mengque Xu Mengsha Cen Xiaoli Chen Haotian Chen Xing Liu Qian Cao |
author_sort |
Mengque Xu |
title |
Correlation between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel Disease |
title_short |
Correlation between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel Disease |
title_full |
Correlation between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel Disease |
title_fullStr |
Correlation between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel Disease |
title_full_unstemmed |
Correlation between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel Disease |
title_sort |
correlation between serological biomarkers and disease activity in patients with inflammatory bowel disease |
publisher |
Hindawi Limited |
series |
BioMed Research International |
issn |
2314-6133 2314-6141 |
publishDate |
2019-01-01 |
description |
Background. Current biomarkers have been routinely used noninvasive methods for assessing disease activity of inflammatory bowel disease (IBD), but none of them are specific. This study was aimed to determine the performance of the serological biomarkers for detecting disease activity in patients with IBD. Methods. A prospective study that included 73 ulcerative disease (UC) subjects, 141 Crohn’s disease (CD) subjects, and 30 of them complicated with C. difficile infection (CDI) were diagnosed at a single-institution IBD center. Disease activity was assessed using by Truelove and Witts criteria for UC and Harvey Bradshaw Simple Index for CD. Serological inflammatory biomarkers were compared in different severity groups. Receiver operator curve analyses assessed the performance of each biomarker in discriminating disease states. Results. For UC patients, elevated monocyte counts, C-reactive protein (CRP), and decreased lymphocyte counts and lymphocyte/monocyte ratio (LMR) significantly differed between subjects with active and inactive UC. LMR of 3.1 was 76% sensitive and had a specificity of 67% for active UC. For CD patients, higher values of neutrophils, monocytes, neutrophil/lymphocyte ratio, CRP, fibrinogen, and lower values of LMR and hemoglobin were significantly different between subjects with active and inactive CD. None of the biomarkers included had a good correlation with disease activity (area under the ROC Curve < 0.70). Conclusions. A low LMR represents an inexpensive, readily available test with a promising value to identify disease activity in UC patients, whereas none of the inflammatory biomarkers showed a discriminative value in disease activity of CD. |
url |
http://dx.doi.org/10.1155/2019/6517549 |
work_keys_str_mv |
AT mengquexu correlationbetweenserologicalbiomarkersanddiseaseactivityinpatientswithinflammatoryboweldisease AT mengshacen correlationbetweenserologicalbiomarkersanddiseaseactivityinpatientswithinflammatoryboweldisease AT xiaolichen correlationbetweenserologicalbiomarkersanddiseaseactivityinpatientswithinflammatoryboweldisease AT haotianchen correlationbetweenserologicalbiomarkersanddiseaseactivityinpatientswithinflammatoryboweldisease AT xingliu correlationbetweenserologicalbiomarkersanddiseaseactivityinpatientswithinflammatoryboweldisease AT qiancao correlationbetweenserologicalbiomarkersanddiseaseactivityinpatientswithinflammatoryboweldisease |
_version_ |
1725396808988884992 |